Rare Genetic Epilepsy Responsive To Marinus's Ganaxolone

Meets Primary Endpoint In Phase III MARIGOLD Study

 
• By John Davis
  
Marigolds
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D